| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458655 | Radiotherapy and Oncology | 2018 | 5 Pages |
Abstract
The high incidence of PRO scores and weak agreement to CTCAE suggest that PROs are important tools complementary to CTCAE in evaluating patient symptoms during and after CRT. Proton therapy has the potential to lower radiation doses to most organs at risk.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Camilla Kronborg, Eva Serup-Hansen, Anna Lefevre, Eva E. Wilken, Jørgen B. Petersen, Jolanta Hansen, Annette Schouboe, Lars Nyvang, Karen-Lise G. Spindler,